Human Immunodeficiency Virus Rapid Test Kits Market Size 2024-2028 

The human immunodeficiency virus (HIV) rapid test kits market size is forecast to increase by USD 294.96 million at a CAGR of 6.52% between 2023 and 2028. The market is experiencing significant growth due to several key trends. The rise in awareness programs for HIV testing is a major driver, as more individuals are becoming conscious of the importance of early detection and treatment. Additionally, efforts to increase pre-marital screenings for HIV are gaining momentum, particularly in regions with high HIV prevalence rates. However, challenges remain, including the non-availability of rapid HIV products in limited-resource settings, which hampers widespread testing and diagnosis. Despite these challenges, advancements in technology and increasing government initiatives to improve access to HIV testing are expected to fuel market growth.

 Request Free Sample

The market is witnessing significant growth due to the increasing demand for HIV testing, both in healthcare settings and at home. The availability of rapid HIV testing has revolutionized HIV diagnostics, enabling healthcare professionals and providers to obtain accurate results within minutes using blood samples. This has been instrumental in improving HIV prevention efforts and public health programs. Moreover, the market is expanding beyond traditional blood samples to include oral fluid testing using saliva samples. This innovation offers convenience and versatility, making HIV testing more accessible to a wider population. Awareness campaigns and digital tools are also driving the growth of the market by increasing public knowledge about HIV infection and the importance of regular testing.

Home use HIV testing kits are gaining popularity, allowing individuals to test themselves in private and confidential settings. Additionally, the use of HIV testing kits in blood transfusions is ensuring the safety of the blood supply and reducing the risk of HIV transmission.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

• End-user
  • Diagnostic centers
  • Hospitals
  • clinics
• Type
  • HIV rapid immunoassay test
  • HIV rapid molecular diagnostic test
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
  • Asia
  • Rest of World (ROW)

By End-user Insights

The diagnostic centers segment is estimated to witness significant growth during the forecast period. The market has witnessed significant growth due to the increasing awareness campaigns and public health programs aimed at early HIV detection. These tests are crucial for HIV prevention and treatment, as timely diagnosis can reduce HIV-related mortality. HIV rapid tests are available in various formats, including those using blood samples and oral fluid testing with saliva samples. Healthcare professionals and providers administer these tests in diagnostic centers, hospitals, and clinics. HIV rapid test kits can detect HIV-1 and HIV-2 antibodies and antigens, such as p24 antigen, in serum, saliva, or urine samples. Some tests can also detect HIV RNA.

These kits offer precision and versatility, making them suitable for use in underdeveloped nations and for home use. Digital tools and HIV self-testing kits are gaining popularity, providing convenience and confidentiality. The demand for HIV rapid tests is driven by the need for HIV detection in blood transfusions and donations. These tests are essential for reducing the risk of HIV transmission through blood products. The market for HIV rapid test kits is expected to continue growing due to the increasing awareness, availability of tests, and the need for early detection to reduce the death rate from HIV infection. Pharmaceutical companies are investing in the development and production of these kits to meet the growing demand.

Get a glance at the market share of various segments Request Free Sample

The diagnostic centers segment was valued at USD 369.38 million in 2018 and showed a gradual increase during the forecast period.

Regional Insights

North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Request Free Sample

The market in North America is witnessing significant growth due to the increasing incidence and prevalence of HIV infections. According to public health programs and awareness campaigns, early detection of HIV is crucial for effective prevention and treatment. Rapid HIV testing using blood samples, oral fluid testing with saliva samples, and urine samples have gained popularity due to their precision and versatility. Healthcare professionals and providers are increasingly using these HIV testing kits for home use and in clinical settings to diagnose HIV infection promptly. HIV self-testing using digital tools is also gaining traction, especially in underdeveloped nations with limited access to healthcare facilities.

The demand for HIV diagnostics is escalating due to the importance of identifying HIV infection for initiating antiretroviral therapy and reducing HIV-related mortality. Pharmaceutical companies are investing in the development of advanced HIV testing kits that can detect HIV antibodies, antigens, RNA, and other biomarkers in various body fluids, including serum, saliva, and urine samples. The rising number of HIV infections, especially among teenage pregnancies, and the need for HIV prevention measures, such as blood transfusions and blood donations, are further fueling the growth of the HIV rapid test kits market.

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Driver

The rise in awareness programs for HIV testing is the key driver of the market. The market plays a crucial role in public health programs by enabling early detection of HIV infection through various sampling methods, including blood samples and oral fluid testing using saliva samples. These tests offer precision and versatility, making HIV testing more accessible to individuals, particularly in underdeveloped nations. Healthcare professionals and providers employ these HIV testing kits for diagnosing HIV infection through the detection of antibodies, antigens, RNA, or serum samples from body tests like blood, urine, or saliva. Awareness campaigns and digital tools have significantly increased the adoption of HIV self-testing, allowing individuals to test themselves in the comfort of their homes.

This trend is particularly important for high-risk groups, such as teenage pregnancies, and those involved in blood transfusions or blood donations. The reduction in HIV-related mortality and death rate underscores the importance of HIV diagnostics and the role of pharmaceuticals in managing the infection. The provision of HIV counseling and testing plays an essential role in increasing awareness and preventing new infections, with organizations like the American Institutes for Research (AIR) supporting HIV prevention efforts through strategic support to public health programs and communication with stakeholders.

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Trends

Efforts to increase pre-marital screenings for HIV is the upcoming trend in the market. HIV infection continues to pose a significant challenge to public health programs worldwide, with millions of new cases reported annually. To combat this global health crisis, various initiatives have been implemented by governments and healthcare providers. One such initiative includes pre-marital HIV testing, which involves assessing the HIV status of soon-to-be-married couples to prevent the transmission of the virus. This testing can be conducted using various methods, including blood samples, oral fluid testing using saliva samples, and urine samples. The use of rapid HIV testing kits has gained popularity due to their precision and versatility. These kits can detect HIV-1 and HIV-2 antibodies, antigens, and RNA in body fluids.

Awareness campaigns and digital tools have increased accessibility to HIV testing, enabling self-testing at home and reducing the stigma associated with HIV diagnosis. Healthcare professionals and providers are also promoting the use of HIV testing kits in blood transfusions and blood donations to ensure safety. In underdeveloped nations, where access to healthcare facilities is limited, rapid HIV testing kits offer an affordable and convenient solution. Despite advancements in HIV prevention and treatment, the HIV-related mortality rate remains high, making the use of rapid HIV testing kits an essential tool in the fight against this disease. Pharmaceuticals and healthcare industries are continuously innovating to improve the accuracy and affordability of these kits, making them accessible to a larger population.

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Challenge

Non-availability of rapid HIV products in limited-resource settings is a key challenge affecting the market growth. HIV, a significant public health concern, causes considerable perinatal morbidity and mortality worldwide. Cost-effectiveness is a crucial consideration in the selection of HIV diagnostic tests for healthcare systems. Factors influencing the cost-effectiveness of HIV screening include HIV prevalence, geographical location, and the cost comparison between conventional and rapid test kits. In many underdeveloped nations, the lack of access to rapid test kits contributes to a high number of undiagnosed HIV cases. HIV rapid testing, an affordable diagnostic solution, offers precision and versatility through various sample types such as blood, saliva, and urine. Awareness campaigns and healthcare providers' education on HIV prevention and self-testing using digital tools and home use HIV testing kits can increase early detection and reduce HIV-related mortality.

Pharmaceuticals and healthcare professionals play a vital role in promoting the use of HIV diagnostics, including blood samples, serum, and RNA tests, in blood transfusions and donations. Oral fluid testing using saliva samples is an emerging trend in HIV diagnostics, offering convenience and ease of use. Overall, the use of rapid HIV testing kits can significantly reduce the death rate associated with HIV infection.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

AccuQuik Test Kits: The company offers human immunodeficiency virus (HIV) rapid test kits, namely AccuQuik, which is a chromatographic immunoassay for the qualitative detection of antibodies raised against human immunodeficiency virus in human serum, plasma or blood.

The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Abbott Laboratories
• Amkay Products Pvt. Ltd.
• Becton Dickinson and Co.
• Bhat Bio Tech India Pvt Ltd.
• bioLytical Laboratories Inc.
• bioMerieux SA
• Chembio Diagnostics Inc.
• Danaher Corp.
• DrSafeHands
• F. Hoffmann La Roche Ltd.
• Fujirebio Holdings Inc.
• Healgen Scientific, LLC
• Hologic Inc.
• J. Mitra and Co. Pvt. Ltd.
• MP Biomedicals Inc.
• Oragenics Inc.
• OraSure Technologies Inc.
• Pathkits Heathcare Pvt. Ltd.
• SHINE SA

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

The market is witnessing significant growth due to the increasing awareness campaigns and public health programs aimed at early detection and prevention of HIV infection. These tests provide precision and versatility, allowing for the use of various samples such as blood, oral fluid, saliva, and urine. Healthcare professionals and providers are increasingly utilizing HIV testing kits for home use, blood transfusions, and blood donations to reduce the risk of HIV-related mortality. The market is also driven by the availability of digital tools and advancements in HIV diagnostics, enabling the detection of HIV-1 and HIV-2, as well as the identification of antibodies, antigens, and even RNA.

In underdeveloped nations, where disposable income may be limited, oral fluid testing using saliva samples has emerged as a cost-effective alternative to traditional blood tests. The market is expected to continue growing, driven by the ongoing efforts to reduce the global death rate from HIV infection.

Request Free Sample

What are the Key Data Covered in this Market Research and Growth Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
• Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch